At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 80 enrolled
Drug / intervention
AbobotulinumtoxinA dose 1 +3 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Randomized, Dose-Ranging, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Moderate to Severe Platysmal Bands
In Brief
A Phase 2 clinical trial evaluating AbobotulinumtoxinA dose 1, Placebo, and 2 other interventions for Platysmal Bands. Completed, enrolled 80 participants across 8 sites.
Detailed Summary
Interventional phase 2 study to evaluate safety and efficacy of abobotulinumtoxinA for the treatment of platysmal bands.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPlatysmal Bands
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2020202120222023202420252026
First PostedSep 2019
Enrollment StartSep 2019
Primary CompletionDec 2019
Study CompletionJun 2020
TodayJul 2026
First PostedSep 6, 2019
Enrollment StartSep 25, 2019
Primary CompletionDec 30, 2019
Study CompletionJun 4, 2020
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 6.8 years ago
Interventions
AbobotulinumtoxinA dose 1biological
Treatment of platysmal bands
Placeboother
Treatment of platysmal bands
AbobotulinumtoxinA dose 2biological
Treatment of platysmal bands
AbobotulinumtoxinA dose 3biological
Treatment of platysmal bands